BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22451307)

  • 1. Pyruvate prevents the inhibition of the long-term potentiation induced by amyloid-β through protein phosphatase 2A inactivation.
    Wang X; Takata T; Bai X; Ou F; Yokono K; Sakurai T
    J Alzheimers Dis; 2012; 30(3):665-73. PubMed ID: 22451307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Exp Neurol; 2015 Sep; 271():145-54. PubMed ID: 26057947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation.
    Zhao D; Watson JB; Xie CW
    J Neurophysiol; 2004 Nov; 92(5):2853-8. PubMed ID: 15212428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
    Zhang JF; Qi JS; Qiao JT
    Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
    Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II.
    Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ
    J Neurosci Res; 2002 Nov; 70(3):298-308. PubMed ID: 12391589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 prevents amyloid β-induced impairment of long-term potentiation in hippocampal slices via ErbB4.
    Min SS; An J; Lee JH; Seol GH; Im JH; Kim HS; Baik TK; Woo RS
    Neurosci Lett; 2011 Nov; 505(1):6-9. PubMed ID: 21787838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gly(14)]-humanin rescues long-term potentiation from amyloid beta protein-induced impairment in the rat hippocampal CA1 region in vivo.
    Guo F; Jing W; Ma CG; Wu MN; Zhang JF; Li XY; Qi JS
    Synapse; 2010 Jan; 64(1):83-91. PubMed ID: 19768812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domoic acid induces a long-lasting enhancement of CA1 field responses and impairs tetanus-induced long-term potentiation in rat hippocampal slices.
    Qiu S; Jebelli AK; Ashe JH; Currás-Collazo MC
    Toxicol Sci; 2009 Sep; 111(1):140-50. PubMed ID: 19564213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices.
    Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z
    Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5.
    Wang Q; Walsh DM; Rowan MJ; Selkoe DJ; Anwyl R
    J Neurosci; 2004 Mar; 24(13):3370-8. PubMed ID: 15056716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+/calmodulin-dependent protein kinase II-dependent long-term potentiation in the rat suprachiasmatic nucleus and its inhibition by melatonin.
    Fukunaga K; Horikawa K; Shibata S; Takeuchi Y; Miyamoto E
    J Neurosci Res; 2002 Dec; 70(6):799-807. PubMed ID: 12444602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine.
    Klyubin I; Wang Q; Reed MN; Irving EA; Upton N; Hofmeister J; Cleary JP; Anwyl R; Rowan MJ
    Neurobiol Aging; 2011 Apr; 32(4):614-23. PubMed ID: 19446369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraneuronally injected amyloid β inhibits long-term potentiation in rat hippocampal slices.
    Nomura I; Takechi H; Kato N
    J Neurophysiol; 2012 May; 107(9):2526-31. PubMed ID: 22338026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
    Bisel BE; Henkins KM; Parfitt KD
    Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.
    Nomura I; Kato N; Kita T; Takechi H
    Neurosci Lett; 2005 Dec; 391(1-2):1-6. PubMed ID: 16154266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
    Wu MN; He YX; Guo F; Qi JS
    Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation.
    Moriguchi S; Shioda N; Han F; Yeh JZ; Narahashi T; Fukunaga K
    Hippocampus; 2009 Sep; 19(9):844-54. PubMed ID: 19253410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.